India to Hong Kong: Mycophenolate Export Trade Route

The India to Hong Kong Mycophenolate corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $3.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $1.2M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with mycophenolate's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 31.7%, placing it at rank #8 among India's top mycophenolate export destinations globally.

On the import side, key buyers of Indian mycophenolate in Hong Kong include I & C (HONGKONG) LIMITED, TO STANDARD CHARTERED , PHARMASON COMPANY LIMITED. I & C (HONGKONG) LIMITED is the single largest importer with 1 shipments valued at $3.5M USD.

India's mycophenolate exports to Hong Kong are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Hong Kong benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.2M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as phr drugs & medi accord mycophenolate 50 and pharma drug&med: accord mycophenolate 500mg/v 1v(acc-hk) each vial contains : mycophenolate mofetil (as hydrochloride) e, suggesting that buyers in Hong Kong tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, I & C (HONGKONG) LIMITED is the largest importer with 1 shipments worth $3.5M USD — representing 98% of all mycophenolate imports from India on this route.